Stay updated with breaking news from Crispr. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
A new form of gene therapy uses CRISPR editing to create T-cells that hunt cancer cells. Although still in its very early stages, the treatment offers hope for those suffering from untreatable cancer.
The “most complicated therapy ever” tailors bespoke, genome-edited immune cells to attack tumors
In a small study, researchers modified patients’ immune cells to target their particular cancer—but it only worked for a third of volunteers.
Researchers have reported on the first ever human trials to use this technology to train the immune system to fight cancer.
Using CRISPR gene editing, the immune receptors are used to redirect immune cells to recognize cancer.